| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.81B | 156.73B | 158.28B | 156.66B | 143.03B | 130.20B |
| Gross Profit | 13.29B | 12.55B | 11.55B | 11.70B | 10.89B | 9.31B |
| EBITDA | 5.62B | 5.01B | 4.39B | 3.59B | 3.93B | 2.08B |
| Net Income | 3.60B | 3.38B | 2.75B | 1.72B | 2.41B | 1.20B |
Balance Sheet | ||||||
| Total Assets | 75.10B | 74.63B | 85.36B | 81.28B | 76.95B | 70.65B |
| Cash, Cash Equivalents and Short-Term Investments | 8.51B | 8.38B | 9.60B | 8.42B | 5.25B | 9.44B |
| Total Debt | 3.60B | 1.60B | 4.99B | 7.95B | 7.59B | 5.51B |
| Total Liabilities | 36.74B | 35.72B | 46.57B | 45.35B | 40.98B | 35.95B |
| Stockholders Equity | 37.76B | 38.47B | 38.31B | 35.48B | 35.68B | 34.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.16B | 5.43B | 4.01B | -3.38B | 3.96B |
| Operating Cash Flow | 0.00 | 4.33B | 5.66B | 4.07B | -3.31B | 4.49B |
| Investing Cash Flow | 0.00 | 350.00M | -202.00M | 804.00M | -320.00M | -542.00M |
| Financing Cash Flow | 0.00 | -5.81B | -4.35B | -1.72B | -670.00M | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥110.23B | 14.20 | ― | 3.38% | 10.74% | -26.50% | |
78 Outperform | ¥48.00B | 5.27 | ― | 3.87% | 2.66% | -11.41% | |
73 Outperform | ¥53.65B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
67 Neutral | ¥32.45B | 14.30 | ― | 4.05% | -3.82% | 18.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.23B | 15.26 | ― | 3.17% | 5.95% | 23.97% | |
61 Neutral | ¥159.65B | 9.98 | ― | 2.42% | 9.74% | 6.48% |